Nutrien Ltd.

TSX:NTR Rapport sur les actions

Capitalisation boursière : CA$49.6b

Nutrien Croissance future

Future contrôle des critères 0/6

Les bénéfices de Nutrien devraient diminuer de 2.1% par an tandis que son chiffre d'affaires annuel devrait croître de 1% par an. Le BPA devrait croître de diminuer de 1.2% par an. Le rendement des capitaux propres devrait être 7.9% dans 3 ans.

Informations clés

-2.1%

Taux de croissance des bénéfices

-1.19%

Taux de croissance du BPA

Chemicals croissance des bénéfices5.6%
Taux de croissance des recettes1.0%
Rendement futur des capitaux propres7.94%
Couverture par les analystes

Good

Dernière mise à jour05 May 2026

Mises à jour récentes de la croissance future

Nutrien Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Aug 08
Nutrien Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Nutrien Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 09
Nutrien Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Recent updates

NTR: Tighter Fertilizer Markets And DOJ Probe Will Shape Future Returns

The updated analyst price target for Nutrien reflects a small decrease of about CA$0.26. Analysts are balancing slightly softer implied revenue growth and a marginally higher discount rate against firmer profit margin assumptions and a modestly lower future P/E multiple.

NTR: Tighter Fertilizer Markets And DOJ Probe Will Shape Balanced Outlook

The analyst price target for Nutrien has risen by CA$4.18. Analysts attribute this change to updated assumptions for slightly stronger revenue growth, higher profit margins, and a lower future P/E multiple, reflecting the recent wave of higher sector targets and tighter global fertilizer markets.

NTR: Tighter Fertilizer Markets And DOJ Probe Will Pressure Future Returns

Analysts have nudged the fair value estimate for Nutrien higher to CA$95.41. This reflects a modestly lower discount rate, slightly firmer long term margin assumptions, and updated sector P/E comparisons that incorporate a wave of recent price target increases tied to tighter fertilizer markets and higher commodity pricing expectations.

NTR: Higher Fertilizer Pricing And DOJ Probe Will Shape Share Performance

Analysts have lifted the average Nutrien price target by roughly CA$31 to around CA$95, citing stronger fertilizer pricing, higher expected profit margins and support for elevated sector valuation multiples, despite more cautious views on volume growth. Analyst Commentary Recent research on Nutrien largely centers on fertilizer pricing, geopolitical risks and the earnings impact of tighter nitrogen and potash markets.

NTR: Nutrient Pricing, Portfolio Actions And DOJ Probe Will Shape Balanced Outlook

The analyst price target for Nutrien has increased to CA$101.07 from CA$96.56, as analysts factor in firmer nutrient pricing expectations, potential nitrogen upside tied to recent geopolitical events, and company-specific portfolio actions that they view as supportive of earnings stability and cash generation. Analyst Commentary Recent research points to a broadly constructive tone around Nutrien, with multiple firms updating models after the Q4 report and adjusting price targets on the back of nutrient pricing assumptions, portfolio moves, and expected cash generation.

NTR: Firmer Nutrient Pricing And Potash Supply Risks Will Shape Balanced Returns

Our updated fair value estimate for Nutrien edges higher to CA$96.56 from CA$91.99, reflecting a series of analyst price target increases tied to refreshed models after recent results, stronger assumed profit margins, and expectations that nutrient pricing holds firmer for longer, even as some remain cautious about future potash supply. Analyst Commentary Street research on Nutrien has been active, with several firms revisiting their models and adjusting price targets around recent and upcoming quarterly results.

NTR: Reassessed P/E And Farm Headwinds Will Shape Balanced Returns Ahead

Analysts have raised our Nutrien fair value estimate to $91.99 from $88.43, as recent price target increases and rating changes suggest a reassessment of the stock's risk profile, growth outlook, and appropriate future P/E multiple. Analyst Commentary Recent Street research on Nutrien has become more constructive, with several firms increasing price targets or improving ratings while others remain cautious on end market conditions and sector headwinds.

NTR: Higher Fertilizer Pricing And Buybacks Will Support Future Upside

Our analyst price target for Nutrien edges slightly lower to about $112.49 from $113.03, as analysts weigh mixed sector commentary on fertilizer and agriculture markets against recent target adjustments and an updated future P/E assumption of roughly 20.2x. Analyst Commentary Recent Street research on Nutrien reflects mixed sector views but a generally supportive tone on the company, with several bullish analysts adjusting targets and ratings while acknowledging a more cautious backdrop for fertilizers and agriculture.

NTR: Fertilizer Cycle Concerns Will Pressure Shares Despite Recent Buybacks

Narrative Update Analysts have nudged their consolidated price target for Nutrien down by about $2 to $64. This reflects updated views that factor in more cautious fertilizer and agriculture setups, modestly lower assumed revenue growth, a slightly higher profit margin profile, and a reduced future P/E multiple in their models.

NTR Is Expected To Benefit From Potential Upside In Fertilizer Pricing

Analysts have modestly reduced their price target on Nutrien to approximately $113 from about $97, citing a tougher near term backdrop for farmers, slightly lower growth and margin expectations, and a more balanced risk reward profile after the stock's strong run. Analyst Commentary Recent Street research reflects a mixed but generally constructive stance on Nutrien, with several firms trimming price targets modestly while maintaining positive ratings.

NTR: Portfolio Streamlining And Farm Headwinds Will Shape Balanced Returns Ahead

Analysts have modestly reduced their price expectations for Nutrien, trimming the target by a low single digit dollar amount to reflect a tougher near term farm income backdrop, portfolio streamlining impacts, and a more balanced risk reward view despite solid recent execution. Analyst Commentary Street research on Nutrien reflects a constructive long term view, tempered by nearer term caution around farm fundamentals, commodity pricing and the impact of recent portfolio moves.

NTR: Portfolio Streamlining And Asset Sales Will Drive Sector Outperformance Ahead

Nutrien's analyst price target has been modestly reduced by $0.21 to $88.43. Analysts cite ongoing sector headwinds, including weaker crop prices, portfolio adjustments, and a more balanced risk-reward outlook, despite solid recent performance.

NTR: Portfolio Streamlining and Supply Tightness Will Shape Upside Amid Sector Scrutiny

Nutrien’s average analyst price target has edged slightly lower in recent weeks, as analysts weigh a modestly improving profit margin and fair value estimate against easing revenue growth and persistent caution over the agricultural cycle. Analyst Commentary Recent analyst activity around Nutrien highlights both opportunities and challenges for the company as it navigates ongoing market volatility and shifting sector dynamics.

Shifting Market Trends Will Shape Fertilizer Demand Amid Agricultural Cycle Uncertainty

Nutrien's analyst price targets have recently edged lower by $1 to $2 per share, as analysts cite cautious earnings expectations, a more balanced risk-reward profile, and the impact of portfolio adjustments on future performance. Analyst Commentary Recent Street research highlights a divided outlook among analysts covering Nutrien, reflecting both positive and cautionary perspectives as the company navigates its next phase of growth and portfolio transformation.

Global Food Demand And Precision Ag Will Secure Fertilizer Success

Analysts have modestly raised their price target for Nutrien, increasing it by approximately $1.38 to reflect updated earnings projections and evolving outlooks for fertilizer market conditions. Analyst Commentary Recent street research reflects a mixed outlook on Nutrien's growth trajectory, valuation, and near-term execution capacity.

With Nutrien Ltd. (TSE:NTR) It Looks Like You'll Get What You Pay For

Sep 08
With Nutrien Ltd. (TSE:NTR) It Looks Like You'll Get What You Pay For

Nutrien Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Aug 08
Nutrien Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Nutrien (TSE:NTR) Has Some Way To Go To Become A Multi-Bagger

Jul 16
Nutrien (TSE:NTR) Has Some Way To Go To Become A Multi-Bagger

A Look At The Fair Value Of Nutrien Ltd. (TSE:NTR)

Jul 03
A Look At The Fair Value Of Nutrien Ltd. (TSE:NTR)

Nutrien Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 09
Nutrien Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
User avatar

Accelerated Efficiency And Expanded Potash And Nitrogen Output Will Strengthen Future Operations

Accelerated operational efficiency and strategic sales expansion may enhance margins and boost revenue without significant new capital expenditure.

Prévisions de croissance des bénéfices et des revenus

TSX:NTR - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/202826,9992,5002,0794,6478
12/31/202726,8042,3752,5764,99714
12/31/202627,1732,5442,8035,17914
12/31/202525,9492,2672,0024,007N/A
9/30/202525,6711,8092,1324,153N/A
6/30/202525,0211,3631,6723,671N/A
3/31/202524,7395278392,940N/A
12/31/202425,0166741,3813,535N/A
9/30/202425,5567332,4654,562N/A
6/30/202425,8397902,7785,001N/A
3/31/202427,3258452,9495,437N/A
12/31/202328,0821,2582,4665,066N/A
9/30/202329,9672,1982,7515,652N/A
6/30/202332,5833,7004,0966,999N/A
3/31/202335,4666,8534,7257,314N/A
12/31/202237,0127,6605,6358,110N/A
9/30/202236,7927,7494,9017,011N/A
6/30/202234,6126,8892,6024,568N/A
3/31/202229,8684,4042,0993,976N/A
12/31/202126,8613,1532,0023,886N/A
9/30/202123,6422,2681,2543,027N/A
6/30/202121,8619642,3413,907N/A
3/31/202120,5146212,1853,697N/A
12/31/202020,0534591,7743,323N/A
9/30/202019,534951,3542,964N/A
6/30/202019,4708232,3524,238N/A
3/31/202019,7549161,6963,654N/A
12/31/201919,3169921,7743,665N/A
9/30/201919,6711,336N/A3,214N/A
6/30/201919,449128N/A2,448N/A
3/31/201918,86211N/A1,877N/A
12/31/201818,772-31N/A2,052N/A
9/30/201816,051-447N/A465N/A
6/30/201813,376636N/A935N/A
3/31/20186,48947N/A662N/A
12/31/20174,010154N/A1,225N/A
9/30/20173,973196N/A1,197N/A
6/30/20173,893261N/A1,199N/A
3/31/20173,824230N/A1,295N/A
12/31/20163,921199N/A1,260N/A
9/30/20164,239478N/A1,530N/A
6/30/20164,658679N/A1,593N/A
3/31/20165,330975N/A2,005N/A
12/31/20155,7911,115N/A2,338N/A
9/30/20156,3031,476N/A2,428N/A
6/30/20156,4021,511N/A2,644N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Les bénéfices de NTR devraient diminuer au cours des 3 prochaines années ( -2.1% par an).

Bénéfices vs marché: Les bénéfices de NTR devraient diminuer au cours des 3 prochaines années ( -2.1% par an).

Croissance élevée des bénéfices: Les bénéfices de NTR devraient baisser au cours des trois prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de NTR ( 1% par an) devrait croître plus lentement que le marché de Canadian ( 5% par an).

Croissance élevée des revenus: Le chiffre d'affaires de NTR ( 1% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de NTR devrait être faible dans 3 ans ( 7.9 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/05/05 14:15
Cours de l'action en fin de journée2026/05/05 00:00
Les revenus2025/12/31
Revenus annuels2025/12/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Nutrien Ltd. est couverte par 52 analystes. 15 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Harriet LiAccountability Research Corporation
Keith CarpenterATB Cormark
Benjamin TheurerBarclays